In this case study, a retrospective analysis was performed using data from a metastatic breast cancer patient. The patient was given five lines of treatment; the first four quickly failed and the fifth was highly successful. The analysis shows that CureMatch can correctly rank the efficacy of treatment options, and illustrates multiple benefits of using the CureMatch analysis.
This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.
Otherwise, you will be redirected to the institutional part of this website.
Thank you for your understanding.